Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

InvaGen Pharmaceuticals Inc.

Division of Cipla Ltd.
www.invagen.com

Latest From InvaGen Pharmaceuticals Inc.

Lyrica Generics Launch, But Pfizer Has Been Bracing For The Hit

The first generic versions of Pfizer's blockbuster pain medicine pregabalin have launched in the US. Pfizer has guided investors the company will return to growth in 2020 after cycling through the loss.

Generic Drugs Launches

The Quality Lowdown: Deferred Expire Dates, Broadened Import Alerts, Recall Roundup

The US FDA makes it easier for local agencies to extend expiration dates for doxycyline used in emergency situations; more drug quality updates in this week's lowdown.

Manufacturing Quality

Start-Up Quarterly Statistics: Relay, Cerevel Financings Lead Q4 VC Deals

A review of biopharma start-up dealmaking and financing activity from October through December 2018, based on data from Strategic Transactions.

Deals Financing

Deal Watch: PDS And Edge Merge To Progress HPV-Linked Cancer Immunotherapy

Immunotherapy firms Edge and PDS announce planned merger, while Telix advances its prostate cancer strategy by acquiring ANMI. Kyowa Hakko Kirin is signed up to distribute GlaxoSmithKline's Phase III CKD-associated anemia product daprodustat in Japan.

Deals M & A
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Drug Delivery
      • Controlled Release
    • Generic Drugs
  • Therapeutic Areas
  • Cardiovascular
  • Infectious & Viral Diseases
  • Inflammation
  • Metabolic Disorders
  • Neurology, Nervous System
  • Alias(es)
  • InvaGen Inc.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Cipla Ltd.
  • Senior Management
  • Sudhakar Vidiyala, PhD, Pres. & CEO
  • Contact Info
  • InvaGen Pharmaceuticals Inc.
    Phone: (631) 231-3233
    7 Oser Ave.
    Hauppauge, NY 11788
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register